Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cells

Toxicology in Vitro

Volumn 26, Issue 3, 2012, Pages 421-428

  Liao, Yanyan ^a   Wang, Jia ^a   Huang, Qian sheng ^a   Fang, Chao ^a   Kiyama, Ryoiti ^b   Shen, Heqing ^a   Dong, Sijun ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Adhesion molecule; EDCs related receptor; HUVECs; Inflammatory response; PFOS; ROS

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PADGEM PROTEIN; PERFLUOROOCTANESULFONIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE;

AROMATIC HYDROCARBON RECEPTOR GENE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ESTROGEN RECEPTOR ALPHA GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERCELLULAR ADHESION MOLECULE 1 GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; NUCLEOTIDE SEQUENCE; PADGEM PROTEIN GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ALKANESULFONIC ACIDS; CELL ADHESION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; P-SELECTIN; TIME FACTORS; UP-REGULATION;

EID: 84862801743     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.01.011     Document Type: Article

References (52)

1. Abbott B.D. Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR [alpha]), beta (PPAR [beta]), and gamma (PPAR [gamma]) in rodent and human development. Reprod. Toxicol. 2009, 27:246-257.
2. Beach S., Newsted J., Coady K., Giesy J. Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS). Rev. Environ. Contam. 2006, 186:133-174.
3. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
4. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Tully J.S., Needham L.L. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Sci. Technol. 2007, 41:2237-2242.
5. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ. Res. 1998, 83:952-959.
6. Chen X.L., Zhang Q., Zhao R., Ding X., Tummala P.E., Medford R.M. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells. J. Pharmacol. Exp. Ther. 2003, 305:573-580.
7. Chen X.L., Zhang Q., Zhao R., Medford R.M. Superoxide, H2O2, and iron are required for TNF-α-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1001-H1007.
8. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
9. Davies M.J., Gordon J., Gearing A., Pigott R., Woolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 1993, 171:223-229.
10. Devasagayam T., Tilak J., Boloor K., Sane K., Ghaskadbi S., Lele R. Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Physicians India 2002, 52:794-804.
11. DeWitt J.C., Shnyra A., Badr M.Z., Loveless S.E., Hoban D., Frame S.R., Cunard R., Anderson S.E., Meade B.J., Peden-Adams M.M. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit. Rev. Toxicol. 2009, 39:76-94.
12. Dustin M.L., Rothlein R., Bhan A., Dinarello C., Springer T. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137:245-254.
13. Eriksen K.T., Raaschou-Nielsen O., Sorensen M., Roursgaard M., Loft S., Moller P. Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat. Res. 2010, 700:39-43.
14. Escher P., Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 2000, 448:121-138.
15. Frijns C.J.M. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002, 33:2115-2122.
16. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 2001, 35:1339-1342.
17. Gong E.Y., Park E., Lee K. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells. Cancer Sci. 2010, 101:2019-2025.
18. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 344:721-724.
19. Halliwell B., Gutteridge J., Cross C. Free radicals, antioxidants, and human disease: where are we now?. J. Lab. Clin. Med. 1992, 119:598-620.
20. Harris M.T., Feldberg R.S., Lau K.M., Lazarus N.H., Cochrane D.E. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate 2000, 44:19-25.
21. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C.G. Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 2006, 40:3463-3473.
22. Houseknecht K.L., Cole B.M., Steele P.J. Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: a review. Domest. Anim. Endocrinol. 2002, 22:1-23.
23. Hu X.Z., Hu D.C. Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Arch. Toxicol. 2009, 83:851-861.
24. Jensen E.V., Jordan V.C. The estrogen receptor: a model for molecular medicine. Clin. Cancer Res. 2003, 9:1980-1989.
25. Jung Y., Song S., Choi C. Peroxisome proliferator activated receptor gamma agonists suppress TNF alpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species. Immunol. Lett. 2008, 117:63-69.
26. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Jesus Olivero O., Van Wouwe N., Yang J.H. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
27. Kannan K., Tao L., Sinclair E., Pastva S.D., Jude D.J., Giesy J.P. Perfluorinated compounds in aquatic organisms at various trophic levels in a great lakes food chain. Arch. Environ. Contam. Toxicol. 2005, 48:559-566.
28. Key B.D., Howell R.D., Criddle C.S. Fluorinated organics in the biosphere. Environ. Sci. Technol. 1997, 31:2445-2454.
29. Krovel A., Softeland L., Torstensen B., Olsvik P. Transcriptional effects of PFOS in isolated hepatocytes from Atlantic salmon Salmo salar L. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2008, 148:14-22.
30. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
31. Liu C., Du Y., Zhou B. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat. Toxicol. 2007, 85:267-277.
32. T method. Methods 2001, 25:402-408.
33. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics. 2006, 7:497-508.
34. Mollenhauer M., Bradshaw S., Fair P., McGuinn W.D., Peden-Adams M. Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 2011, 46:97-108.
35. Naile J.E., Khim J.S., Wang T., Chen C., Luo W., Kwon B.O., Park J., Koh C.H., Jones P.D., Lu Y. Perfluorinated compounds in water, sediment, soil and biota from estuarine and coastal areas of Korea. Environ. Pollut. 2010, 158:1237-1244.
36. Olsen, G., Logan, P., Simpson, C., Burris, J., Burlew, M., Lundberg, J., Mandel, J., 2001. Descriptive summary of serum fluorochemical levels among employee participants of the year 2000 Decatur fluorochemical medical surveillance program. St Paul, MN, 3M Company EPA Docket AR-226.
37. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 2003, 45:260-270.
38. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
39. Peshavariya H.M., Dusting G.J., Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic. Res. 2007, 41:699-712.
40. Prober J. Cytokine mediated activation of vascular endothelium: physiology and pathology. Am. J. Pathol. 1988, 133:426-433.
41. Puri J., Hutchins B., Bellinger L.L., Kramer P.R. Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint. Reprod. Biol. Endocrinol. 2009, 7:155.
42. Qazi M.R., Bogdanska J., Butenhoff J.L., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 2009, 262:207-214.
43. Qian Y., Ducatman A., Ward R., Leonard S., Bukowski V., Lan Guo N., Shi X., Vallyathan V., Castranova V. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J. Toxicol. Environ. Health A 2010, 73:819-836.
44. Roosens L., D'Hollander W., Bervoets L., Reynders H., Van Campenhout K., Cornelis C., Van Den Heuvel R., Koppen G., Covaci A. Brominated flame retardants and perfluorinated chemicals, two groups of persistent contaminants in Belgian human blood and milk. Environ. Pollut. 2010, 158:2546-2552.
45. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., Drexler H. Role of NAD (P) H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ. Res. 2000, 87:1195-1201.
46. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 2002, 68:249-264.
47. Stossi F. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 2004, 145:3473-3486.
48. Takacs M.L., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol. Sci. 2006, 95:108-117.
49. Tarrade A., Schoonjans K., Guibourdenche J., Bidart J., Vidaud M., Auwerx J., Rochette-Egly C., Evain-Brion D. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 2001, 142:4504-4514.
50. Toms L.M.L., Calafat A.M., Kato K., Thompson J., Harden F., Hobson P., Sjodin A., Mueller J.F. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ. Sci. Technol. 2009, 43:4194-4199.
51. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., Quinn M.T., Pagano P.J., Johnson C., Alexander R.W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 2002, 91:1160-1167.
52. Yaghmaie F., Saeed O., Garan S.A., Freitag W., Timiras P.S., Sternberg H. Caloric restriction reduces cell loss and maintains estrogen receptor-alpha immunoreactivity in the pre-optic hypothalamus of female B6D2F1 mice. Neuro. Endocrinol. Lett. 2005, 26:197-203.